Search | IOVS | ARVO Journals

Showing 1 – 20 of 56

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

The Influence of Dark and Light Adaptation on Phosphene Thresholds Elicited with DTL Electrodes

renan rocha memória; Santana José Galdino Souza; Rodrigo Jorge; Andre Messias

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5879. doi:

ARVO Annual Meeting Abstract June 2017

Bevacizumab or Triamcinolone for Persistent Diabetic Macular Edema: 24-week preliminary results

Murilo Wendeborn Rodrigues; Andre Messias; Jose Augusto Cardillo; Rubens C Siqueira; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):954. doi:

ARVO Annual Meeting Abstract June 2017

Combined Pars Plana Vitrectomy (PPV) and Phacoemulsification (Phaco) versus PPV and Deferred Phaco for Patients with Macular Hole (MH) or Epiretinal Membrane (ERM)

Rodrigo Jorge; Karlos Italo Viana; David Lucena; Marcelo Menegatti Esperandio; Denny Marcos Garcia; Felipe Piacentini Almeida; Andre Messias; Ingrid U Scott

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2805. doi:

ARVO Annual Meeting Abstract June 2017

Spatial correlation between localized decreases in the exploratory visual search performance and areas of glaucomatous visual field loss.

Jayter Silva Paula; CASSIA SENGER; Marcelo Jordão Lopes Silva; C Gustavo De Moraes; Andre Messias

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2850. doi:

ARVO Annual Meeting Abstract September 2016

Intravitreal Autologous Bone Marrow Derived Stem Cells in Dry Age-related Macular Degeneration

Rubens C Siqueira; Carina Costa Cotrim; Andre Messias; Monique Viana de Sousa; Luiza Toscano; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3704. doi:

ARVO Annual Meeting Abstract September 2016

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Maculopathy Results after 12 Months Follow-up

Felipe Placeres Borges; Rubens C Siqueira; Murilo Wendeborn Rodrigues; Amanda Jardim Dos Santos; Andre Messias; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3741. doi:

ARVO Annual Meeting Abstract September 2016

Correlation of visual field defects and exploratory visual search performance in open angle glaucoma patients using a computer digit-based task

CASSIA SENGER; Andre Messias; Jayter Silva Paula

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3906. doi:

ARVO Annual Meeting Abstract September 2016

Corneal curvature is a key determinant of Haigis and SRKT formulae accuracy of for intentional myopic overcorrection

Andre Messias; Rodrigo Faeda Dalto; Ferreira Miriam; Wilian Queiroz; Roberto Pinto Coelho; Jayter Silva Paula

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3103. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal Autologous Bone-Marrow Stem Cells in nonexudative macular degeneration (dry AMD) patients: Results after 3 Months Follow-up

Carina Costa Cotrim; Rodrigo Jorge; Andre Messias; Monique Viana de Sousa; Luiza Toscano; Rubens C Siqueira

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3783. doi:

ARVO Annual Meeting Abstract June 2015

Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)

Rubens C Siqueira; Andre Messias; Katharina Messias; Rafael Arcieri; Milton A Ruiz; Neiglene F Souza; Lia C Martins; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3812. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal Autologous Bone Marrow Derived Cells in Stargardt disease patients: Results after 3 months follow-up

Luiza Toscano; Carina Costa Cotrim; Rodrigo Jorge; Andre Messias; Rubens C Siqueira

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3828. doi:

ARVO Annual Meeting Abstract June 2015

ERG Findings after One Year Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation Treatment for Proliferative Diabetic Retinopathy

Katharina Messias; Rafael de Montier Barroso; Fabiano Sakamoto; Vinicius Monteiro de Castro; Amanda Marega; Rodrigo Jorge; Andre Messias

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):764. doi:

ARVO Annual Meeting Abstract June 2015

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Macular Edema - Results after 6 Months Follow-up

Monique Viana de Sousa; Rodrigo Jorge; Andre Messias; Carina Costa Cotrim; Murilo Wendeborn Rodrigues; Rubens C Siqueira

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4718. doi:

ARVO Annual Meeting Abstract June 2015

Comparative efficacy of two different regimens of povidone-iodine 5% eye drops instillation in reducing conjunctival bacterial flora

Leticia Barroso; Antonio Brunno Nepomuceno; Sarah P. Cazella; Luiza Toscano; Jefferson Ribeiro; Andre Messias; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):279. doi:

ARVO Annual Meeting Abstract June 2015

PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy treatment

Rafael de Montier Barroso; Andre Messias; Jose A Cardillo; Rodrigo Jorge; Ophthalmology Department, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1773. doi:

ARVO Annual Meeting Abstract June 2015

Full-field Stimulus Threshold (FST) Changes After Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation in Proliferative Diabetic Retinopathy

Andre Messias; Katharina Messias; Rafael de Montier Barroso; Amanda Marega; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1776. doi:

ARVO Annual Meeting Abstract April 2014

Neuroprotective Effects of Intravitreal Triamcinolone Acetonide and Dexamethasone Implant in Rabbit Retinas After Pars Plana Vitrectomy and Silicone Oil Injection

Rubens C Siqueira; Wagner F Santos; Ingrid U Scott; Andre Messias; Marcela N Rosa; Gabriella F Cunha; Armando c Junior; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5747. doi:

ARVO Annual Meeting Abstract April 2014

Chromatic Full-field Stimulus Threshold (FST) in Proliferative Diabetic Retinopathy

Andre Messias; Katharina Messias; Rafael Saran Arcieri; Fabiano Sakamoto; Vinicius M Castro; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):335. doi:

ARVO Annual Meeting Abstract April 2014

Electroretinographic findings after Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation in Proliferative Diabetic Retinopathy - 6 Months Results

Carina Costa Cotrim; Rodrigo Jorge; Andre Messias; Katharina Messias; Rafael de Montier Barroso

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3895. doi:

ARVO Annual Meeting Abstract April 2014

PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy

Rafael de Montier Barroso; Andre Messias; Rodrigo Jorge

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3904. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The Influence of Dark and Light Adaptation on Phosphene Thresholds Elicited with DTL Electrodes

Bevacizumab or Triamcinolone for Persistent Diabetic Macular Edema: 24-week preliminary results

Combined Pars Plana Vitrectomy (PPV) and Phacoemulsification (Phaco) versus PPV and Deferred Phaco for Patients with Macular Hole (MH) or Epiretinal Membrane (ERM)

Spatial correlation between localized decreases in the exploratory visual search performance and areas of glaucomatous visual field loss.

Intravitreal Autologous Bone Marrow Derived Stem Cells in Dry Age-related Macular Degeneration

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Maculopathy Results after 12 Months Follow-up

Correlation of visual field defects and exploratory visual search performance in open angle glaucoma patients using a computer digit-based task

Corneal curvature is a key determinant of Haigis and SRKT formulae accuracy of for intentional myopic overcorrection

Intravitreal Autologous Bone-Marrow Stem Cells in nonexudative macular degeneration (dry AMD) patients: Results after 3 Months Follow-up

Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)

Intravitreal Autologous Bone Marrow Derived Cells in Stargardt disease patients: Results after 3 months follow-up

ERG Findings after One Year Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation Treatment for Proliferative Diabetic Retinopathy

Intravitreal Autologous Bone Marrow Derived Stem Cells in Ischemic Macular Edema - Results after 6 Months Follow-up

Comparative efficacy of two different regimens of povidone-iodine 5% eye drops instillation in reducing conjunctival bacterial flora

PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy treatment

Full-field Stimulus Threshold (FST) Changes After Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation in Proliferative Diabetic Retinopathy

Neuroprotective Effects of Intravitreal Triamcinolone Acetonide and Dexamethasone Implant in Rabbit Retinas After Pars Plana Vitrectomy and Silicone Oil Injection

Chromatic Full-field Stimulus Threshold (FST) in Proliferative Diabetic Retinopathy

Electroretinographic findings after Intravitreal Ranibizumab and Single or Multiple Spot Panphotocoagulation in Proliferative Diabetic Retinopathy - 6 Months Results

PASCAL panretinal photocoagulation (PRP) versus ETDRS PRP associated with intravitreal Ranibizumab (IVR) versus only IVR for proliferative diabetic retinopathy

To View More...

You must be signed into an individual account to use this feature.